Key Takeaways
Most people hear about semaglutide from a friend who lost weight on it, a news segment talking about the medication, or, most commonly, a social media thread. Then they start searching about what it actually is, how it works, and if it’s right for their weight loss goals.
Those are the right questions to ask before starting any weight loss program. In this guide, we’ll give straightforward answers to these pressing questions. You’ll find a clear explanation of what semaglutide is, how it works inside the body, what compounded semaglutide means, how long it typically takes to see changes, and who this is and is not a good fit for.
At InjectCo, our nurse-led clinical team has guided patients across Texas through personalized, physician-supervised weight loss programs for years. We believe you make better decisions when you understand the medication your provider is considering for you, and this comprehensive guide gives you just the foundation you need.
Semaglutide is a prescription medication classified as a GLP-1 receptor agonist. It works by mimicking a hormone your body produces naturally called glucagon-like peptide-1, which signals to the brain that you have eaten enough. When that signal is stronger and more sustained, appetite decreases, calorie intake lowers, and the body creates conditions that support gradual weight reduction over time.
The medication was originally developed for the management of type 2 diabetes. However, researchers noticed that patients using it for blood sugar control were also losing weight, which led to extended studies focused specifically on obesity management. This research formed the basis of the medically supervised weight loss programs we see in clinics across Texas today.
InjectCo’s semaglutide weight loss program requires a valid prescription from a licensed medical provider, including a telehealth consultation or in-clinic evaluation before the program can begin. Remember, no reputable program prescribes it without this step, so it’s best to first consult a trusted clinic or provider to assess their approach before you commit to anything.
For your guidance, here’s how semaglutide for weight loss works.
Your body releases GLP-1 after you eat. This hormone tells the pancreas to release insulin, slows how quickly food leaves the stomach, and signals the brain that you are satisfied or satiated (full). For many people who struggle with their weight in general, this system is less responsive than it should be. Appetite stays elevated, fullness signals arrive late, and eating more than the body actually needs becomes the path of least resistance. Overall, this leads to harmful eating habits, and, ultimately, unnecessary weight gain.
Semaglutide acts on the same receptor that GLP-1 targets. Because it stays in the body longer than the hormone your body produces on its own, its effect on appetite suppression essentially becomes more sustained. This is why patients in medically supervised programs often describe their relationship with food as no longer feeling like something they have to fight against.
A 2024 review of semaglutide’s mechanism published in PMC summarizes the receptor-level process in clinical detail for those who want the peer-reviewed version.
One patient we saw recently, a woman in her mid-40s from the Dallas-Fort Worth area, described her first few weeks in the program this way: “I kept waiting to get really hungry, and it just did not happen the way it always had before.” What we tell patients like her is that this is the medication doing what it is designed to do, which is a clinical adjustment to appetite signaling, managed within a physician-supervised program.
If you are curious whether this approach is right for you, our team offers free virtual consultations across Texas. See if you qualify for InjectCo’s medically supervised weight loss program.
Compounded semaglutide is a version of the medication prepared by a licensed compounding pharmacy using a pharmaceutical-grade, active ingredient. Compounding pharmacies create custom formulations under the supervision of a licensed pharmacist. The result is a version of semaglutide that is not an FDA-approved finished drug product.
This distinction matters, as it’s important to understand that compounded medications are NOT FDA-approved products. But they are legally prescribed when prepared by a licensed 503A or 503B compounding pharmacy and authorized by a licensed medical provider. At InjectCo, all medications within our programs are sourced through a licensed 503B compounding pharmacy partner.
The reason many programs use compounded versions often relates to accessibility and program structures. Your provider determines whether this is clinically appropriate for your situation during your evaluation based on your health history, goals, and current medications.
If cost is a factor in your decision, the semaglutide cost without insurance breakdown on our website walks through what patients in different program types typically pay, including compounded versus brand-name options.
The short answer: Yes. Oral semaglutide, including sublingual drops, is a legitimate form of the semaglutide medication used in weight loss programs. The mechanism of action is the same as the injectable form. Overall, the practical difference is in how the medication is absorbed, and, for many patients, how convenient daily dosing feels compared to once-weekly injections.
InjectCo offers both injectable and oral compounded semaglutide options. Sublingual drops are taken once daily under the tongue, typically at least 30 minutes before eating. For patients who are hesitant about injections, this is a clinically meaningful and convenient alternative that’s worth discussing with your provider.
One honest note worth sharing, though, is that the bioavailability of oral semaglutide is lower than its injectable counterpart, meaning the body absorbs a smaller percentage of the active ingredient. Your provider will factor this into your program design and dosing approach. Don’t worry; this doesn’t make oral semaglutide less appropriate for the right patient. Instead, it just comes with a different dosing protocol.
For patients choosing the injectable route, our comprehensive semaglutide injection sites guide walks you through technique, rotation, and the best practices for each location. Medications are prescribed at the discretion of a licensed provider and may not be appropriate for every patient.
In our Fort Worth clinic, most patients tell us the first thing they notice is early appetite changes within the first one to two weeks of starting a program that includes semaglutide. Noticeable changes in body weight typically become visible around weeks 4 through 8, with more significant progress showing around the three-month mark for patients who stay consistent with the full program.
How fast semaglutide works depends on several variables, such as your starting dose, how the dose is titrated over time, your metabolism, any co-existing health conditions, and how consistently you follow the lifestyle guidance your provider gives alongside the program. No provider can guarantee a specific rate of weight loss for any individual patient.
A landmark NEJM study on once-weekly semaglutide for weight management provides clinical trial data on outcomes in medically supervised settings for reference.
For a full breakdown of how doses change over time, the semaglutide dosing schedule explained covers the titration approach from starting dose through the maintenance phase.
Results may vary. Also, this program may not be suitable for everyone, so it’s best to consult with your medical provider before starting any weight loss program.
Book my free weight loss consultation
Or text our team at (817) 533-7676 | Se habla espanol: (469) 804-9964
Semaglutide is not appropriate for everyone, and knowing this before you consult matters. Your provider will screen for the following conditions before prescribing.
Patients who typically do not qualify include those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Patients with a history of pancreatitis, certain kidney conditions, or severe gastrointestinal disease will require careful individual evaluation.
Women who are pregnant, planning to become pregnant, or currently breastfeeding should not take semaglutide. If you are on insulin or other blood-sugar-affecting medications, that information is essential for your provider’s assessment.
Side effects that some patients experience, particularly in the early weeks of a program, include nausea, vomiting, diarrhea, and constipation. These are the most commonly reported. Not all patients experience them. Your provider will review potential risks and considerations specific to your health history during your evaluation.
Patients exploring coverage options for physician-supervised weight loss programs may find the HSA and FSA eligibility guide for semaglutide programs useful before their consultation.
InjectCo is a nurse-led, physician-supervised medical aesthetics and wellness company with 9 locations across Texas. Our clinical team brings 75 combined years of experience across injectables and weight management programs.
Here is how the program works for new patients: You start with a virtual or in-person consultation. A licensed provider reviews your health history, current medications, and weight loss goals. If semaglutide is clinically appropriate for your situation, a prescription is issued through our licensed 503B pharmacy partner.
Monthly check-ins with your provider, including ongoing progress tracking, dose adjustments based on your body’s response to the medication, and access to your licensed provider between appointments, are all built into InjectCo’s physician-supervised program.
Our compounded semaglutide program is available across our nine Texas locations, with telehealth access statewide. InjectCo’s semaglutide weight loss program in Fort Worth and semaglutide program in Colleyville are two of our most active clinic locations for weight management patients.
For patients who want to see real-life patient experiences before deciding, the semaglutide before and after stories section on our blog reflects outcomes from across the InjectCo network.
Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on two hormone receptors. Both are prescription medications used in physician-supervised weight loss programs. Your provider will determine which, if either, is clinically appropriate for your situation based on your health profile and program goals. InjectCo offers both medications through physician evaluation.
Alcohol is generally not recommended during a semaglutide weight loss program, as it can worsen nausea and other gastrointestinal side effects that some patients experience early in the program. It also generally works against your calorie goals. For such concerns, it’s best to talk to your provider about your specific situation before making any assumptions.
Patients with a personal or family history of medullary thyroid carcinoma or MEN 2, those with pancreatitis history, pregnant or breastfeeding women, and patients on certain diabetes medications typically do not qualify for the semaglutide program. Rest assured that your provider at InjectCo will conduct a full patient evaluation before any prescription is issued.
Injectable semaglutide has a half-life of approximately one week, which is why once-weekly dosing is standard for the injectable form. Oral forms, on the other hand, are taken daily because they clear the system faster. For optimal results, your InjectCo provider’s dosing protocol is designed around how your body reacts to the medication.
Yes, but stopping abruptly without a transition plan often leads to returning appetite and weight gain. For patients who want to stop semaglutide, most healthcare providers recommend a structured tapering approach combined with continued lifestyle support. Our guide on maintaining weight after stopping semaglutide covers this in greater detail.
Yes, InjectCo offers telehealth consultations for patients across Texas. Your semaglutide medication, when prescribed as part of our physician-supervised program, is managed through a licensed pharmacy and delivered to your home. Text (817) 533-7676 or visit InjectCo’s weight loss program to get started.
Semaglutide can lower blood sugar levels. For patients without diabetes, this is generally managed safely within a medically supervised program through proper dosing and monitoring. Don’t worry; your provider at InjectCo will review any signs of low blood sugar, particularly if you are taking other medications that affect glucose.
